For the first time, the anti-steatotic action of an amphibian skin peptide, namely macrotympanain A1 (MA1- FLPGLECVW), has been demonstrated in a well-established in vitro model of hepatic steatosis. Here, PNMA1 is linked to Hepatic steatosis.